Medigen Vaccine Biologics Corporation approved the election of Ming-Yi,Wu, Managing Partner of Reanda M Y Wu & Co., CPAs, as independent director and member of audit and remuneration committees, at the 2023 AGM. Effective date of the new appointment is June 29, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.3 TWD | -1.35% | +5.77% | -26.82% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.82% | 517M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
-9.14% | 11.95B | |
+5.24% | 8.71B | |
-8.42% | 8.12B |
- Stock Market
- Equities
- 6547 Stock
- News Medigen Vaccine Biologics Corporation
- Medigen Vaccine Biologics Corporation Approves the Election of Ming-Yi ,Wu as Independent Director and Member of Audit and Remuneration Committees